Abstract Background Post-operative moderate-to-severe mitral regurgitation (MR) following transcatheter aortic valve replacement (TAVR) is associated with poor outcomes, yet the
Surgical valve technologies Transcatheter heart valves technologies
Abstract Background Post-operative moderate-to-severe mitral regurgitation (MR) following transcatheter aortic valve replacement (TAVR) is associated with poor outcomes, yet the
Surgical valve technologies Transcatheter heart valves technologies
Abstract Background Acute kidney injury (AKI) following transcatheter aortic valve implantation (TAVI) is associated with significantly worse outcomes, leading to
Transcatheter heart valves technologies
Abstract Background The prevalence of aortic valve stenosis is on the rise, primarily due to an aging population. Transcatheter
Transcatheter heart valves technologies
Abstract Background New-onset postoperative atrial fibrillation (POAF) is common after transcatheter aortic valve replacement (TAVR). At present, the impact of
Transcatheter heart valves technologies
Abstract Background Right ventricular (RV) function assessment by echocardiography can be challenging due to its complex morphology. Also, increasing use
Transcatheter heart valves technologies
Abstract Background Glycemic control is critical for managing transcatheter aortic valve replacement (TAVR) patients, especially those in intensive care units
Transcatheter heart valves technologies
Abstract Background Transcatheter aortic valve replacement (TAVR) has emerged as a major therapeutic option for treating aortic stenosis. Hyponatremia is
Transcatheter heart valves technologies
Abstract Background We used transcatheter aortic valve implantation (TAVI) procedure time to investigate the association between surgical team maturity and
Transcatheter heart valves technologies
Abstract Background The aim of this study was to investigate whether the level of decrease in cerebral oxygen saturation during
Transcatheter heart valves technologies
Abstract Background Acute kidney injury (AKI) complicates transcatheter aortic valve replacement (TAVR), leading to higher mortality. The incidence and effects